12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Company News  |  Deals

Biolucidation LLC, Melior deal

Melior acquired all assets of CRO Biolucidation, which specialized in drug abuse liability studies. Melior said the acquisition significantly expands its preclinical pharmacology capabilities. Melior is using...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >